Global Health (MEDANTA) Share Price Falls 2.29% as MEDANTA Declines on 28 August
- August 28, 2026
- Posted by: Harsh Piplani
- Category: News
Global Health Share Price moved lower on 28 August 2026, with MEDANTA closing at Rs 1,478 after a 2.29% decline. The company’s market capitalisation stood at Rs 39,278.13 crore, placing it in the Large Cap category. The supplied data confirms the share price fall and today’s range, but it does not establish a company-specific catalyst for the move. For readers tracking Global Health Share Price Today and MEDANTA Stock News, the session matters because it shows a clear same-day price decline against a healthcare industry backdrop that can be compared with sector benchmarks on Univest.
The move is relevant because the stock opened above the close, traded between Rs 1,476 and Rs 1,527.5, and ended below the previous close of Rs 1,512.6. Today’s decline of Rs 34.6 is factual market data, while turnover of Rs 2.93 crore gives a traded-value reference for the session. Univest tracks these updates so investors can read Global Health Share Price News in a structured way that separates observed price action from unsupported explanation.
Global Health (MEDANTA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,478 |
| Previous Close | Rs 1,512.6 |
| Today's Move | -Rs 34.60 (-2.29%) |
| Open | Rs 1,520 |
| High | Rs 1,527.5 |
| Low | Rs 1,476 |
| Turnover | Rs 2.93 crore |
| Market Capitalisation | Rs 39,278.13 crore |
| Market Cap Category | Large Cap |
Global Health Share Price Today reflected a clear negative session. The stock opened at Rs 1,520, moved to an intraday high of Rs 1,527.5 and a low of Rs 1,476, before settling at Rs 1,478. That leaves the close Rs 34.6 below the previous close of Rs 1,512.6, or 2.29% lower on the day. The trading range was Rs 51.5 from high to low, which helps frame the day’s price action without adding interpretation beyond the supplied data.
MEDANTA Stock News for the session is best read through the close relative to the open and previous close. The stock finished below the opening level of Rs 1,520 and also below the previous close, which confirms the day’s share price fall. Turnover stood at Rs 2.93 crore, a factual value that belongs in the session record but cannot be used as a reason for the move. With a Rs 39,278.13 crore market capitalisation and Large Cap classification, Global Health remains a sizeable listed healthcare company, and today’s decline should be viewed within that context. The next step for Global Health Share Price analysis is to place this session alongside valuation and sector comparisons.
Global Health (MEDANTA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 39,278.13 crore |
| P/E Ratio | 73.12x |
| P/B Ratio | 9.89x |
| ROE | 15.12% |
| ROCE | 19.38% |
| EPS | Rs 20.69 |
| Book Value Per Share | Rs 152.92 |
| Dividend Yield | 0.03% |
EPS is Rs 20.69, book value is Rs 152.92 per share and dividend yield is 0.03%. Those three metrics add balance to Global Health Fundamental Analysis: EPS reflects earnings attributable to each share, book value shows accounting net worth per share and dividend yield reflects the historical payout relative to current price. In isolation, these figures do not explain the fall in Global Health Share Price, but they do provide the financial backdrop that investors often use when reviewing MEDANTA Latest News and MEDANTA Financial Results on Univest.
Global Health has a market capitalisation of Rs 39,278.13 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 73.12x, P/B at 9.89x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.12% and ROCE of 19.38%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 20.69, book value per share of Rs 152.92, dividend yield of 0.03%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 48.76x, median ROE of 12.82%, median ROCE of 14.97%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 73.12x |
| Benchmark Median P/E | 48.76x |
| Benchmark Average P/E | 122.29x |
| Benchmark P/E Range | 7.92x to 1,563.88x |
| Company P/B Ratio | 9.89x |
| Benchmark Median P/B | 4.2x |
| Benchmark Average P/B | 4.84x |
| Company ROE | 15.12% |
| Benchmark Median ROE | 12.82% |
| Benchmark Average ROE | 13.83% |
| Company ROCE | 19.38% |
| Benchmark Median ROCE | 14.97% |
| Benchmark Average ROCE | 3.1% |
| Company Market Capitalisation | Rs 39,278.13 crore |
| Benchmark Median Market Cap | Rs 721.33 crore |
| Benchmark Average Market Cap | Rs 12,215.63 crore |
Global Health operates in Healthcare, within the Hospital & Healthcare Services industry. The sector snapshot covers 62 companies in the same industry, which makes the benchmark broad enough to compare valuation and return measures without overfitting the analysis to one or two names. For Global Health Share Price, the company P/E of 73.12 sits above the benchmark median P/E of 48.76 and below the benchmark average of 122.29. That places MEDANTA on the higher side versus the median, while still far below the benchmark maximum of 1,563.88.
The company P/B of 9.89 is above the benchmark median P/B of 4.2 and above the benchmark average of 4.84. ROE at 15.12% is above the benchmark median ROE of 12.82% and above the benchmark average of 13.83%. ROCE at 19.38% is above the benchmark median ROCE of 14.97%. The benchmark scope is the same industry, with 61 companies counted for ROE and ROCE and 62 for P/E, P/B and market capitalisation. The sector median market capitalisation is Rs 721.33 crore and the average is Rs 12,215.63 crore, while Global Health Market Cap is Rs 39,278.13 crore. This is the factual sector context that matters for MEDANTA Share Price Today and for Univest readers comparing company quality with industry norms.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | APOLLOHOSP | 1,26,386.71 | 60.59 | 13.07 | 23.54 | 21.73 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 1,04,736.91 | 117.56 | 5.75 | 12.95 | 13.93 |
| Max Healthcare Institute | MAXHEALTH | 98,495.58 | 67.34 | 8.98 | 14.53 | 14.97 |
| Fortis Healthcare | FORTIS | 69,305.16 | 66.01 | 6.81 | 11.32 | 14.07 |
| Aster DM Healthcare | ASTERDM | 66,438.87 | 380.67 | 13.99 | 9.32 | 11.46 |
Peer comparison shows how Global Health Share Price sits relative to listed healthcare names on the supplied benchmark. MEDANTA’s P/E of 73.12 is above Apollo Hospitals Enterprise at 60.59 and Max Healthcare Institute at 67.34, but below Manipal Health Enterpri L at 117.56 and far below Aster DM Healthcare at 380.67. On P/B, Global Health at 9.89 is below Apollo’s 13.07 and Aster’s 13.99, but above Max Healthcare’s 8.98 and above Fortis Healthcare at 6.81.
In return metrics, MEDANTA’s ROE of 15.12% is below Apollo’s 23.54% and Dr. Lal Pathlabs at 22.37%, but above Max Healthcare at 14.53% and Fortis at 11.32%. ROCE of 19.38% is above Apollo at 21.73? No, Apollo’s ROCE is higher at 21.73%, while Dr. Lal Pathlabs is at 29.56%, Max Healthcare at 14.97% and Fortis at 14.07%. The company’s market cap of Rs 39,278.13 crore is smaller than Apollo, Manipal Health, Max Healthcare and Fortis in the supplied set, but larger than several other peers in the same healthcare group. Univest uses this comparison so MEDANTA Stock News can be read in a relative, not isolated, framework.
Why Investors Are Watching Global Health
- Global Health Share Price closed at Rs 1,478 after falling 2.29% from the previous close of Rs 1,512.6.
- The stock moved between Rs 1,476 and Rs 1,527.5 after opening at Rs 1,520.
- Turnover for the session was Rs 2.93 crore.
- P/E is 73.12, P/B is 9.89, ROE is 15.12% and ROCE is 19.38%.
- Healthcare peer data shows MEDANTA below Apollo on ROE and market cap, while remaining above some other listed peers on returns.
About Global Health
Global Health is part of the Healthcare sector and the Hospital & Healthcare Services industry. The supplied data identifies the company through its listed identity as MEDANTA and places it within a Large Cap market-cap category. For readers following Global Health Stock News, this classification and industry context are the basic company facts that frame the share price discussion.
In Univest coverage, this business profile is intentionally concise and factual. The available dataset supports the sector and industry classification, valuation ratios, profitability metrics and market capitalisation, which are the most relevant inputs for Global Health Share Price News and MEDANTA Share Price Live monitoring.
Track Global Health Share Price on Univest
Use Global Health (MEDANTA) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
On Univest, users can track Global Health Share Price, MEDANTA Share Price Today, valuation ratios, shareholding pattern when available, 52-week levels and market insights in one place. The platform also helps readers follow Global Health Stock Analysis, company updates and healthcare peer context without mixing facts and speculation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Global Health Share Price fall today?
Ans. The data confirms that Global Health Share Price fell 2.29% to Rs 1,478 on 28 August 2026. It does not establish a company-specific catalyst, so the move should be treated as verified price action only.
What is the current Global Health Share Price Today?
Ans. Global Health Share Price Today is Rs 1,478. The stock closed below its previous close of Rs 1,512.6 after opening at Rs 1,520, which confirms the day’s negative session in the supplied data.
What was the day’s low and high in Global Health Share Price?
Ans. The day’s low was Rs 1,476 and the high was Rs 1,527.5. This range, along with the opening price of Rs 1,520, frames the session’s price action for MEDANTA Share Price News.
What is Global Health Market Cap?
Ans. Global Health Market Cap is Rs 39,278.13 crore. The dataset classifies the company as a Large Cap, which is a factual size reference and not an explanation for the day’s share price fall.
How does Global Health compare with healthcare peers?
Ans. Global Health has a P/E of 73.12, P/B of 9.89, ROE of 15.12% and ROCE of 19.38%. Compared with peers, it trades below Apollo on P/E and below several peers on ROE.
What do EPS and book value show for Global Health?
Ans. EPS is Rs 20.69 and book value is Rs 152.92 per share. EPS shows earnings attributable to each share, while book value reflects accounting net worth per share in a simple, factual way.
What is the dividend yield for Global Health Share Price?
Ans. The dividend yield is 0.03%. That figure is historical/current data linked to the present share price and should be read as a payout reference, not a promise of future dividend distributions.
